2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the …

K Zeppenfeld, J Tfelt-Hansen, M De Riva… - European heart …, 2022 - academic.oup.com
4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart …

A Sabbag, B Essayagh, JDR Barrera, C Basso… - Europace, 2022 - academic.oup.com
Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …

Replacement myocardial fibrosis in patients with mitral valve prolapse: relation to mitral regurgitation, ventricular remodeling, and arrhythmia

AL Constant Dit Beaufils, O Huttin, A Jobbe-Duval… - Circulation, 2021 - Am Heart Assoc
Background: Mitral valve prolapse (MVP) is a frequent disease that can be complicated by
mitral regurgitation (MR), heart failure, arterial embolism, rhythm disorders, and death. Left …

The mitral annular disjunction of mitral valve prolapse: presentation and outcome

B Essayagh, A Sabbag, C Antoine, G Benfari… - Cardiovascular …, 2021 - jacc.org
Objectives The aim of this study was to assess in patients with mitral valve prolapse (MVP)
mitral annular disjunction (MAD) prevalence, phenotypic characteristics, and long-term …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Prevalence and extent of mitral annular disjunction in structurally normal hearts: comprehensive 3D analysis using cardiac computed tomography

H Toh, S Mori, YU Izawa, H Fujita… - European Heart …, 2021 - academic.oup.com
Aims Mitral annular disjunction is fibrous separation between the attachment of the posterior
mitral leaflet and the basal left ventricular myocardium initially described in dissected hearts …

Myocardial fibrosis at cardiac MRI helps predict adverse clinical outcome in patients with mitral valve prolapse

S Figliozzi, G Georgiopoulos, PM Lopes, KB Bauer… - Radiology, 2023 - pubs.rsna.org
Background Patients with mitral valve prolapse (MVP) may develop adverse outcomes even
in the absence of mitral regurgitation or left ventricular (LV) dysfunction. Purpose To …

Research Opportunities in the Treatment of Mitral Valve Prolapse: JACC Expert Panel

FN Delling, PA Noseworthy, DH Adams… - Journal of the American …, 2022 - jacc.org
In light of the adverse prognosis related to severe mitral regurgitation, heart failure, or
sudden cardiac death in a subset of patients with mitral valve prolapse (MVP), identifying …

Mitral annular disjunction of degenerative mitral regurgitation: three-dimensional evaluation and implications for mitral repair

B Essayagh, F Mantovani, G Benfari, JF Maalouf… - Journal of the American …, 2022 - Elsevier
Background The dynamic consequences of mitral annular disjunction (MAD) on the mitral
apparatus and the left ventricle remain unclear and are crucial in the context of mitral …